Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cell
|
May 20, 1998
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
S J Rodig, M A Meraz, J M White, et al.
Leukemia
|
August 1, 2012
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
J Etchin, Q Sun, A Kentsis, et al.
Cell
|
February 9, 1996
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
M A Meraz, J M White, K C Sheehan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas
S Derks, L K de Klerk, X Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
A Di Federico, S L Alden, J W Smithy, et al.
Leukemia
|
July 24, 2015
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
J Etchin, J Montero, A Berezovskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitors
A Di Federico, L Hong, A Elkrief, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cell
|
May 20, 1998
Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
S J Rodig, M A Meraz, J M White, et al.
Leukemia
|
August 1, 2012
Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
J Etchin, Q Sun, A Kentsis, et al.
Cell
|
February 9, 1996
Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
M A Meraz, J M White, K C Sheehan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 11, 2020
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas
S Derks, L K de Klerk, X Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2024
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
A Di Federico, S L Alden, J W Smithy, et al.
Leukemia
|
July 24, 2015
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice
J Etchin, J Montero, A Berezovskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2024
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRAS<sup>G12C</sup> inhibitors
A Di Federico, L Hong, A Elkrief, et al.
Page
of 1